Evidence map›Paper›PMID 40661540›Full record

ArticlebioRxiv : the preprint server for biology2025

Glis3 is a modifier of cyst progression in autosomal dominant polycystic kidney disease.

Zemeng Wei, Jianlei Gu, Xin Tian, Chao Zhang, Hongyu Zhao, Stefan Somlo

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Zemeng WeiDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Jianlei GuDepartment of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
Xin TianDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Chao ZhangDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Hongyu ZhaoDepartment of Genetics, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-1195-9607
Stefan SomloDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5062-4629

Funding

In vivo Pathway Discovery in Autosomal Dominant Polycystic Kidney DiseaseRC2DK120534 · NIDDK · YALE UNIVERSITY · PI CAPLAN, MICHAEL J., SHULMAN, GERALD I · 2019 to 2023
$6.6M
Molecular modulators of polycystin signalingR01DK120911 · NIDDK · YALE UNIVERSITY · PI STEFAN SOMLO · 2019 to 2026
$2.9M
Mechanisms of Polycystin and Cilia Function in ADPKDR01DK100592 · NIDDK · YALE UNIVERSITY · PI SOMLO, STEFAN · 2013 to 2017
$1.8M
NIDDK NIH HHS R01 DK100592NIDDK NIH HHS R01 DK120911NIDDK NIH HHS RC2 DK120534
6 · The paper itself

Abstract

Background: Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations affecting polycystin-1 (PC1) or -2 (PC2). The existence of a 'cilia-dependent cyst activation' (CDCA) pathway has been identified by demonstrating that structurally intact primary cilia are crucial for cyst growth following loss of polycystins. We previously used translating ribosome affinity purification (TRAP) RNA-Seq on pre-cystic mouse kidneys to determine the translatome that meet the criteria for CDCA and identified Methods: We used live cell confocal imaging to study the subcellular localization of Glis3 in the presence or absence of Results: The ciliary localization of Glis3 is not affected by Pkd1 mutation status. Kidney selective Conclusions: Glis3 is a primary cilium localized transcription factor that genetically interacts with

Identifiers

PMID40661540
PMCPMC12258985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.